HILS
Price:
$0.237
Market Cap:
$4.17M
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar IC50 against PI3K-delta and HDAC6, which is also known to downregulate; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor ...[Read more]
Industry
Biotechnology
IPO Date
2022-01-12
Stock Exchange
NASDAQ
Ticker
HILS
According to Hillstream BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.34. This represents a change of -29.24% compared to the average of -0.48 of the last 4 quarters.
The mean historical PE Ratio of Hillstream BioPharma, Inc. over the last ten years is -12.43. The current -0.34 PE Ratio has changed 172.28% with respect to the historical average. Over the past ten years (40 quarters), HILS's PE Ratio was at its highest in in the December 2021 quarter at 3.65. The PE Ratio was at its lowest in in the September 2020 quarter at -27.61.
Average
-12.43
Median
-11.79
Minimum
-33.38
Maximum
-0.03
Discovering the peaks and valleys of Hillstream BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.03
Minimum Annual Increase = -95.62%
Minimum Annual PE Ratio = -33.38
Year | PE Ratio | Change |
---|---|---|
2023 | -0.03 | -95.10% |
2022 | -0.52 | -95.62% |
2021 | -11.79 | -28.35% |
2020 | -16.46 | -50.68% |
The current PE Ratio of Hillstream BioPharma, Inc. (HILS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.11
5-year avg
-12.43
10-year avg
-12.43
Hillstream BioPharma, Inc.’s PE Ratio is less than Virax Biolabs Group Limited (0), greater than Blue Water Vaccines, Inc. (-1.34), less than Revelation Biosciences, Inc. (-0.17), less than Kiora Pharmaceuticals, Inc. (-0.09), less than ZyVersa Therapeutics, Inc. (4.61), less than Palisade Bio, Inc. (-0.10), less than Unicycive Therapeutics, Inc. (-0.31), greater than Apexigen, Inc. (-0.46), greater than Immix Biopharma, Inc. (-0.36), greater than Quoin Pharmaceuticals, Ltd. (-2.98), greater than PaxMedica, Inc. Common Stock (-0.47), less than Cardio Diagnostics Holdings, Inc. (-0.00), greater than null (-0.75),
Company | PE Ratio | Market cap |
---|---|---|
0 | $15.24M | |
-1.34 | $3.41M | |
-0.17 | $1.43M | |
-0.09 | $10.52M | |
4.61 | $2.70M | |
-0.10 | $4.25M | |
-0.31 | $33.41M | |
-0.46 | $9.57M | |
-0.36 | $54.08M | |
-2.98 | $3.06M | |
-0.47 | $834.97K | |
-0.00 | $6.94M | |
-0.75 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hillstream BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hillstream BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hillstream BioPharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Hillstream BioPharma, Inc. (HILS)?
What is the highest PE Ratio for Hillstream BioPharma, Inc. (HILS)?
What is the 3-year average PE Ratio for Hillstream BioPharma, Inc. (HILS)?
What is the 5-year average PE Ratio for Hillstream BioPharma, Inc. (HILS)?
How does the current PE Ratio for Hillstream BioPharma, Inc. (HILS) compare to its historical average?